SPECT/CT imaging with 99mTc-P137 nuclide probe
XJTU1AF2022LSK-356
Unknown other active
Quick answer
SPECT/CT imaging with 99mTc-P137 nuclide probe for Prostate Cancer is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Prostate Cancer
- Phase
- Unknown
- Modality
- other
- Status
- active